We are studying the effects of a new combination treatment of atezolizumab and radiotherapy for patients with metastatic tumors. This trial aims to see if this approach can help improve survival rates and understand its safety.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic tumors occur when cancer cells spread from the original tumor to other parts of the body, affecting organs such as the lungs, liver, and bones. This can happen with various types of cancer, including colorectal, non-small cell lung, renal, and sarcoma.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.